Members

At the 69th World Health Assembly in Geneva in May 2016, IAPO raised the issue of access to health services by chronically ill refugees, migrants and internally displaced people. This issue will be revisited during the forthcoming World Health Assembly in Geneva, Switzerland from 22-27 May, 2017.

IAPO will take on the management of the Patient Research Exchange (PRE) platform from Novartis. This is in effort to allow IAPO member organizations to fully engage with the pharmaceutical industry through research and ‘be the change they wish to see in the pharmaceutical world!’ The Patient...

IAPO is proposing to hold four side-events with various partners this year to celebrate WHO’s contributions made over 70 years towards eradication and controlling diseases, and more importantly, marking the great contribution made by WHO in promoting patient-centred health care and improving evidence based medicine through research, policy development, technical assistance and diplomatic advocacy. The side-events will also trigger the start of patient engagement in the long march towards achieving patient-centred universal health coverage by all Member States by 2030.

Without transparent and accountable health systems, patients are less able to take the proactive role that is needed for patient-centred care to be achieved. National procurement and drug pricing systems that lack robust monitoring mechanisms can become open to corruption and exploitation, posing a...